Plus Therapeutics Approves FY2025 Cash Bonuses: CEO Hedrick Gets $305,663, CFO Sims Gets $149,175

PLUS THERAPEUTICS, INC.

On Feb 9, 2026, Compensation Committee approved discretionary cash bonuses for Named Executive Officers for FY2025.
CEO Marc H. Hedrick received a $305,663 cash bonus; total 2025 compensation was $5,566,732.
CFO Andrew Sims received a $149,175 cash bonus; total 2025 compensation was $1,631,279.
Former CMO Norman LaFrance, who stepped down in June 2024, received $0 compensation in FY2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.